DA32 Life Science Tech Acquisition Corp. is a blank check company incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has assembled a seasoned executive team, board of directors and strategic advisors who individually and collectively bring experience in investing, scaling and commercializing important life sciences tools, diagnostics, and data and analytics platforms to improve human health. While the Company may pursue a business combination target in any business or industry, the Company intends to capitalize on the complementary strengths and operating experience of its management team, board and advisors to identify promising opportunities in the life science technology sector.
Company profile
Ticker
DALS
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
863352988
DALS stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
7 Aug 23
25-NSE
Exchange delisting
28 Jul 23
8-K
DA32 Life Science Tech Acquisition Corp. Announces Redemption of Shares
21 Jul 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Latest ownership filings
SC 13G/A
Saba Capital Management, L.P.
7 Feb 24
SC 13G/A
First Trust Capital Management L.P.
11 Sep 23
4
KEITH CRANDELL
10 Aug 23
4
ROBERT NELSEN
10 Aug 23
SC 13G/A
BlackRock Inc.
8 Aug 23
SC 13D/A
ARCH Venture Fund XI, L.P.
4 Aug 23
SC 13D/A
Section 32 Fund 3, LP
2 Aug 23
4
James E Flynn
1 Aug 23
SC 13D/A
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
1 Aug 23
SC 13D/A
DA32 Sponsor LLC
1 Aug 23
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 303.77 k | 303.77 k | 303.77 k | 303.77 k | 303.77 k | 303.77 k |
Cash burn (monthly) | 131.83 k | 108.47 k | (no burn) | (no burn) | 131.83 k | 272.29 k |
Cash used (since last report) | 1.68 mm | 1.38 mm | n/a | n/a | 1.68 mm | 3.48 mm |
Cash remaining | -1.38 mm | -1.08 mm | n/a | n/a | -1.38 mm | -3.17 mm |
Runway (months of cash) | -10.5 | -10.0 | n/a | n/a | -10.5 | -11.7 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 53 |
Opened positions | 6 |
Closed positions | 5 |
Increased positions | 7 |
Reduced positions | 14 |
13F shares | Current |
---|---|
Total value | 166.74 bn |
Total shares | 34.90 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
ARCH Venture Fund XI | 6.72 mm | $67.15 mm |
Section 32 Fund 3 | 6.12 mm | $61.15 mm |
DA32 Sponsor | 5.12 mm | $51.15 mm |
Vivaldi Asset Management | 2.36 mm | $24.17 bn |
Deerfield Management | 1.60 mm | $16.42 bn |
BLK Blackrock | 1.50 mm | $15.39 bn |
Saba Capital Management | 1.24 mm | $12.73 bn |
Periscope Capital | 1.18 mm | $12.13 bn |
Moore Capital Management | 750.00 k | $7.70 bn |
Millennium Management | 714.10 k | $7.33 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Jul 23 | Deerfield Management | Class A Common Stock | Other | Dispose J | Yes | No | 0 | 1,600,000 | 0.00 | 0 |
28 Jul 23 | ARCH Venture Fund XI | Class A Common Stock | Other | Dispose J | No | No | 0 | 1,600,000 | 0.00 | 0 |
28 Jul 23 | Crandell Keith | Class A Common Stock | Other | Dispose J | Yes | No | 0 | 1,600,000 | 0.00 | 0 |